Skip to content

Non-invasive and Continuous Blood Pressure Monitoring

Comparison of Non-Invasive Wearable Sensors to Radial Arterial Catheterization on Human Subjects

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06887465
Enrollment
100
Registered
2025-03-20
Start date
2025-06-30
Completion date
2025-12-31
Last updated
2025-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Pressure

Keywords

Blood pressure monitoring, Non-invasive Blood Pressure Monitoring

Brief summary

The goal of this observational study is to evaluate the accuracy and reliability of the VeriTrack non-invasive blood pressure monitor compared to radial arterial catheterization in adult surgical patients. The main question it aims to answer is: How well does VeriTrack measure continuous blood pressure compared to an arterial catheter? Researchers will compare VeriTrack readings to arterial line measurements to determine if the VeriTrack provides comparable accuracy and clinical utility. Participants will wear the VeriTrack device during surgery and have a radial arterial catheter placed as part of standard care.

Interventions

Application of the VeriTrack non-invasive blood pressure monitor

Sponsors

Thomas Jefferson University
CollaboratorOTHER
Vena Vitals
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients whose blood pressure will be monitored using an arterial line during their procedure * Patients who have a palpable dorsalis pedis pulse

Exclusion criteria

* Patients who have non-palpable dorsalis pedis pulses * Patients whose limbs are inaccessible for placement of Vena Vitals Wearable * Patients with known allergy to adhesives and/or silicone

Design outcomes

Primary

MeasureTime frameDescription
Accuracy of the VeriTrack device in continuous blood pressure monitoring1-24 hoursSystolic, diastolic, and mean arterial pressure (MAP) values will be compared between the VeriTrack and the arterial line using a Bland-Altman analysis.

Secondary

MeasureTime frameDescription
Blood Pressure Change Accuracy1-24 hoursChanges in sys, dia, and MAP measured by VeriTrack will be evaluated and compared to the changes measured by the arterial line

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026